OncoCyte Corp (OCX)
2.779
+0.23
(+9.00%)
USD |
NASDAQ |
May 02, 16:00
2.76
-0.02
(-0.70%)
After-Hours: 20:00
OncoCyte Total Return Price: 2.779 for May 2, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 02, 2024 | 2.779 |
| May 01, 2024 | 2.55 |
| April 30, 2024 | 2.49 |
| April 29, 2024 | 2.525 |
| April 26, 2024 | 2.48 |
| April 25, 2024 | 2.44 |
| April 24, 2024 | 2.46 |
| April 23, 2024 | 2.455 |
| April 22, 2024 | 2.51 |
| April 19, 2024 | 2.50 |
| April 18, 2024 | 2.56 |
| April 17, 2024 | 2.59 |
| April 16, 2024 | 2.75 |
| April 15, 2024 | 2.53 |
| April 12, 2024 | 2.71 |
| April 11, 2024 | 2.965 |
| April 10, 2024 | 2.907 |
| April 09, 2024 | 2.91 |
| April 08, 2024 | 2.90 |
| April 05, 2024 | 2.90 |
| April 04, 2024 | 2.94 |
| April 03, 2024 | 2.94 |
| April 02, 2024 | 2.93 |
| April 01, 2024 | 2.98 |
| March 28, 2024 | 2.93 |
| Date | Value |
|---|---|
| March 27, 2024 | 2.98 |
| March 26, 2024 | 2.998 |
| March 25, 2024 | 3.018 |
| March 22, 2024 | 3.06 |
| March 21, 2024 | 3.05 |
| March 20, 2024 | 3.07 |
| March 19, 2024 | 3.00 |
| March 18, 2024 | 3.02 |
| March 15, 2024 | 2.98 |
| March 14, 2024 | 2.95 |
| March 13, 2024 | 3.01 |
| March 12, 2024 | 3.01 |
| March 11, 2024 | 2.96 |
| March 08, 2024 | 3.00 |
| March 07, 2024 | 3.00 |
| March 06, 2024 | 3.01 |
| March 05, 2024 | 3.02 |
| March 04, 2024 | 3.00 |
| March 01, 2024 | 3.00 |
| February 29, 2024 | 2.91 |
| February 28, 2024 | 2.96 |
| February 27, 2024 | 2.96 |
| February 26, 2024 | 3.05 |
| February 23, 2024 | 3.065 |
| February 22, 2024 | 3.049 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
2.08
Minimum
Nov 08 2023
130.00
Maximum
Feb 16 2021
37.12
Average
31.40
Median
Oct 28 2019
Total Return Price Benchmarks
| Fonar Corp | 16.34 |
| XWELL Inc | 1.77 |
| ProPhase Labs Inc | 5.31 |
| Applied DNA Sciences Inc | 4.075 |
| Veracyte Inc | 20.19 |